Latest Breaking News On - Charlotte charles lapp - Page 1 : comparemela.com

AIM ImmunoTech Inc (NYSE:AIM) has announced that it is working towards filing an Investigational New Drug (IND) application with the US Food and Drug.

United statesCharlotte charles lappDavid strayerHunter hopkins centerImmunotech incDrug administrationTech incInvestigational new drug